Marc Umscheid serves as Executive at Sonoma Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Marc Umscheid has executed 3 insider transactions totaling $8.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 10, 2017 involved purchasing 600 shares valued at $3.2K.
Marc Umscheid currently holds 3,392 shares of Sonoma Pharmaceuticals, Inc. (SNOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Umscheid has been a net buyer of SNOA stock. They have purchased $8.3K and sold $0 worth of shares.
Marc Umscheid's most recent insider trade was on Aug 10, 2017, when they purchased 600 shares at $5.31 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 6, 2017 | SNOA | $5.1K | Purchase | 750 | $6.82 | Discretionary |